Other older studies reported improvements in sleep-wake function or normalization of sleep in chronic insomniacs, but sample sizes were not clearly reported and methods were limited by older study standards [67]
GLP-1 receptor agonists (GLP-1RAs) are used for glycemic control in diabetes and show potential neuroprotective properties, but their effects on AD and the underlying mechanisms are not well understood
Novo says that in the end, truly ridding the world of obesity, with its dire medical consequences, will require it to pull off its next moonshot: preventing patients from becoming obese in the first place
Until more data emerges, they remain a future possibility, not a current option
R.HningS.et al (2008)
Um, a lot of these things are accidental, uh, where people like, my autoimmune disease is getting better, my allergies are getting better